Abstract
Lung injury resulting from inhaled toxins continues to be associated with significant morbidity and mortality. Inhalation injury, when combined with epidermal burns, increases fluid resuscitation requirements. While cutaneous burns can be excised and grafted, pulmonary mucosa must be protected from secondary injury caused by mechanical ventilation, resuscitation, and infections to allow for host repair mechanisms. Many of the consequences of smoke inhalation result from activation of an inflammatory response with immune mediators which are not completely understood. Morbidity from smoke inhalation results from thermal injury and inhaled toxins.
Keywords: Burn, inhalation, airway, ARDS, bronchoscopy.
Current Respiratory Medicine Reviews
Title:Inhalational Injury: A Brief Review of Pathophysiology, Diagnosis and Treatment
Volume: 11 Issue: 1
Author(s): Delphine Engel and Riyad Karmy-Jones
Affiliation:
Keywords: Burn, inhalation, airway, ARDS, bronchoscopy.
Abstract: Lung injury resulting from inhaled toxins continues to be associated with significant morbidity and mortality. Inhalation injury, when combined with epidermal burns, increases fluid resuscitation requirements. While cutaneous burns can be excised and grafted, pulmonary mucosa must be protected from secondary injury caused by mechanical ventilation, resuscitation, and infections to allow for host repair mechanisms. Many of the consequences of smoke inhalation result from activation of an inflammatory response with immune mediators which are not completely understood. Morbidity from smoke inhalation results from thermal injury and inhaled toxins.
Export Options
About this article
Cite this article as:
Engel Delphine and Karmy-Jones Riyad, Inhalational Injury: A Brief Review of Pathophysiology, Diagnosis and Treatment, Current Respiratory Medicine Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/1573398X1101150706144638
DOI https://dx.doi.org/10.2174/1573398X1101150706144638 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hyperhomocysteinemia, Pteridines and Oxidative Stress
Current Drug Metabolism The Chemistry and Biology of the Bryostatins: Potential PKC Inhibitors in Clinical Development
Current Medicinal Chemistry Mitochondria: Prospective Targets for Neuroprotection in Parkinson's Disease
Current Pharmaceutical Design Antioxidants in Health, Disease and Aging
CNS & Neurological Disorders - Drug Targets Conference Report:5<sup>th</sup> International Conference on Nanotek & Expo, Nov 16-18, 2015, San Antonio TX, USA
CNS & Neurological Disorders - Drug Targets Animal Models for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Quality of Education and Memory Test Performance in Older Men: The New York University Paragraph Recall Test Normative Data
Current Alzheimer Research Biological Role of Formaldehyde, and Cycles Related to Methylation, Demethylation, and Formaldehyde Production
Mini-Reviews in Medicinal Chemistry Decreased Cerebral Perfusion and Oxidative Stress Result in Acute and Delayed Cognitive Impairment
Current Neurovascular Research N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
Current Alzheimer Research Structural Neuroimaging Findings in Major Depressive Disorder Throughout Aging: A Critical Systematic Review of Prospective Studies
CNS & Neurological Disorders - Drug Targets Editorial (Thematic issue: Soluble Beta Amyloid in a Continuum from Physiology to Pathology: Searching the Determinants of its Effects and Designing New Pharmacological Treatments)
Current Pharmaceutical Design Novel Natural and Synthetic Ligands of the Endocannabinoid System
Current Medicinal Chemistry Modulation of Amyloid β Peptide1-42 Cytotoxicity and Aggregation in Vitro by Glucose and Chondroitin Sulfate
Current Alzheimer Research Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Synthetic Lipoproteins as Carriers for Drug Delivery
Current Medicinal Chemistry Identification of Misdiagnosed Fronto-Temporal Dementia using APOE Genotype and Phenotype-Genotype Correlation Analyses
Current Alzheimer Research Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases
Current Pharmaceutical Design Pain Experience in Dementia Subtypes: A Systematic Review
Current Alzheimer Research Asymmetric Dimethylarginine: A Possible Link between Vascular Disease and Dementia
Current Alzheimer Research